Top 10 Fast-growings companies in PCSK9 Inhibitors by Most Patent Filing In 1 Year in the world in 2021 – Discovery

Free Trial

The PCSK9 Inhibitors top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 1 Year PCSK9 Inhibitors Fast-growings in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	AstraZeneca UK Ltd.	Cambridgeshire, United Kingdom	Gastrointestinal infections,Medicine,Simvastatin, ...[+2]	Patent: 7
2	AstraZeneca Plc	Cambridgeshire, United Kingdom	Medicine,Health care,Side effect, ...[+2]	Patent: 7
3	Novartis AG	Basel-Stadt, Switzerland	Dosage form,Health care,Medicine, ...[+2]	Patent: 5
4	Regeneron Pharmaceuticals, Inc.	New York, United States	Monoclonal antibody,Clinical trial,Cholesterol, ...[+2]	Patent: 3
5	Amgen, Inc.	California, United States	Health care,Biopharmaceutical,TUMOR NECROSIS FACTOR BLOCKER, ...[+2]	Patent: 2
6	The Kitasato Institute	Tokyo, Japan	Medical research	Patent: 2
7	Daegu-Gyeongbuk Medical Innovation Foundation	South Korea	Biopharmaceutical	Patent: 2
8	Kyungpook National University Industry-Academic Cooperation	Daegu, South Korea	Asset management,Impact investing,Social Welfare	Patent: 2
9	Kyungpook National University Hospital		Medicine,Internal medicine,Surgery, ...[+2]	Patent: 1
10	Tsinghua University Shenzhen Graduate School	CN		Patent: 1